ACE — Ascelia Pharma AB Share News
0.000.00%
Last trade - 00:00- SEK393.94m
- SEK360.74m
Brief: Ascelia Pharma Q3 Operating Loss Narrows To SEK 29.6 Million
Brief: Ascelia Pharma Announces Successful Final Results
Brief: Ascelia Pharma Q2 Operating Loss At SEK 32.7 Mln
Brief: Ascelia Pharma Appoints Déspina Georgiadou Hedin As New CFO
Brief: Ascelia Pharma: Second US Patent For Oncoral Strengthens Coverage
Brief: Ascelia Pharma Q1 Operating Loss Narrows To SEK 32.6 Mln
Brief: Ascelia Pharma: Orviglance Image Enhancement Of Liver Is Not Reduced By Light Meal
Brief: CFO Kristian Borbos To Leave Ascelia Pharma
Brief: Ascelia Pharma Suspends Clinical Activities In Russia
Brief: Ascelia Pharma Q4 Operating Loss Widens To SEK 39.2 Mln
Brief: Ascelia Pharma Q3 Operating Loss Widens To SEK 32.7 Mln
Brief: Ascelia Pharma Signs Clinical Collaboration Agreement With Taiho Oncology
Brief: Ascelia Pharma Receives Conditional FDA Acceptance For Brand Name Orviglance
Brief: Ascelia Pharma Q1 Operating Loss Widens To SEK 33.7 Mln
Brief: Ascelia Pharma Says Carried Out Directed New Share Issue Raising SEK 200 Mln
Brief: Ascelia Pharma AB intends to carry out a directed new share issue
Brief: Ascelia Pharma Opens U.S. Office In Preparation For Mangoral Launch
Brief: Ascelia Q4 Operating Loss Widens To SEK 27.9 Mln
Brief: Ascelia Pharma Says CMC SPV Divests 687,606 Shares In Co Via Private Placement To Institutional Investors